Files

3.Sia D 2018 Nat Rev Gastr Hepatol.pdf (289.46 KB)

Document type

Article

Version

Accepted version

Publication date

2017-08-02

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/127378

Translating '–omics' results into precision medicine for hepatocellular carcinoma

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1038/nrgastro.2017.103

Abstract

A large-scale comprehensive analysis of hepatocellular carcinoma (HCC) based on the integration of six distinct data platforms has pinpointed novel oncogenic processes and prognostic subgroups. These findings confirm previously identified molecular subclasses and fuel the need for a clear strategy of precision medicine in HCC.

Subject

Càncer de fetge, Immunoteràpia

Subject (English)

Liver cancer, Immunotherapy

Citation

Collections

Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citation

SIA, Daniela and LLOVET I BAYER, Josep Maria. Translating '–omics' results into precision medicine for hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology. 2017. Vol. 14, num. 571-572. [consulted: 17 of June of 2026]. Available at: https://hdl.handle.net/2445/127378

Export metadata

JSON - METS

Share record